Pfizer

William Ringo will retire from his role as senior vice president, Worldwide Business Development, Strategy and Innovation at Pfizer. Kristin Peck will succeed Mr. Ringo. Most recently, Ms. Peck played a leadership role in the integration of Wyeth’s global operations, while serving as senior vice president of Worldwide Strategy and Innovation.

Mr. Ringo joined Pfizer in April 2008, after retiring from Lilly, where over his 28-year tenure he held a number of senior positions. Between working for Lilly and Pfizer he served in leadership roles for both venture capital and biotechnology companies.

“Bill has accomplished a great deal in positioning Pfizer for future success,” said Jeff Kindler, Pfizer’s chairman and chief executive officer. “He has helped diversify Pfizer’s portfolio through our acquisition of Wyeth; worked to create a new world-leading, specialist HIV company, called ViiV Healthcare, through our joint venture with GlaxoSmithKline; and played a leadership role in securing rights to novel, promising compounds.”

Mr. Ringo, whose retirement will be effective April 30, 2010, will help his successor during a transition period. Ms. Peck will assume responsibility for business development activities, ensuring their alignment with Pfizer’s strategic objectives. She will report directly to Mr. Kindler and join Pfizer’s Executive Leadership Team.

“Kristin has already been playing a leadership role in strategic planning for the company. Her knowledge, expertise and energy make her an excellent choice for this leadership position,” Mr. Kindler said. “Kristin will work closely with me and other Pfizer executives to advance our business development goals effectively and with an efficient use of our owners’ capital.”

Ms. Peck joined Pfizer in 2004 in the company’s strategic planning organization. Prior to Pfizer, she was a principal with the Boston Consulting Group, focusing on strategy and merger-related issues in the pharmaceutical and financial services industries, and worked in real estate financial services and private equity at Prudential and The O’Connor Group.